International Patent: CD4 SINGLE-POSITIVE T CELL EXHIBITING MHC CLASS II RESTRICTION AND EXHIBITING T CELL HELPER FUNCTION AND ANTIGEN-SPECIFIC CYTOTOXICITY

GENEVA, Oct. 9 -- JUNTENDO EDUCATIONAL FOUNDATION filed a patent application (JP2026/013947) for “CD4 SINGLE-POSITIVE T CELL EXHIBITING MHC CLASS II RESTRICTION AND EXHIBITING T CELL HELPER FUNCTION AND ANTIGEN-SPECIFIC CYTOTOXICITY”. With publication no. WO/2026/211970, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 5/0783

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....